https://pubmed.ncbi.nlm.nih.gov/23816960/
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung...
Afatinib is associated with prolongation of PFS when compared with standard doublet chemotherapy in patients with advanced lung adenocarcinoma and EGFR...
https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1598/
J9323 Pemetrexed ditromethamine - CanMED: HCPCS
CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedhcpcs
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68001-0549/
68001-0549 Pemetrexed - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/72338-0100/
72338-0100 Pemetrexed - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68001-0552/
68001-0552 Pemetrexed - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedndc
https://pubmed.ncbi.nlm.nih.gov/31138260/
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts...
Our results identify a combination between osimertinib and pemetrexed or cisplatin potentially useful in the treatment of EGFR-mutated NSCLC patients, which...
third generationegfr inhibitorosimertinib
https://pubmed.ncbi.nlm.nih.gov/41928369/
Changes in prescription patterns and drug costs following the launch of generic pemetrexed...
After the introduction of generics, a shift in prescription patterns was observed, with an increasing proportion of products with 800-mg vials. Although mean...
https://pubmed.ncbi.nlm.nih.gov/31880966/?dopt=Abstract
Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in...
In terms of the primary end point of OS, no statistically significant benefit was observed; however, PFS in the total patient population and OS in patients...
https://tobias-lib.uni-tuebingen.de/xmlui/handle/10900/36145
Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II...
https://boris-portal.unibe.ch/entities/publication/ad08017c-1a3a-4f5c-8ffc-960713396f7b
22P Increased schedule-dependent efficiency of pemetrexed-cisplatin combination therapy eliminates...
combination therapyincreasedscheduledependentefficiency
https://pubmed.ncbi.nlm.nih.gov/24989332/
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin...
SS1P given with pemetrexed and cisplatin is safe and well tolerated and exhibits significant antitumor activity in patients with unresectable, advanced pleural...
https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-receives-final-usfda-approval-for-pemetrexed-a-chemotherapy-drug/91810543
Zydus Lifesciences receives final USFDA approval for Pemetrexed a chemotherapy drug, ETHealthworld
Pemetrexed is used to treat certain types of cancers, such as lung cancer and mesothelioma. It is a chemotherapy drug that works by slowing or stopping the...
zydus lifesciences
https://research.birmingham.ac.uk/en/projects/ruxsac-a-double-blind-placebo-controlled-randomized-phase-ii-stud/
RUXSAC -A double blind, placebo-controlled, randomized phase II study of Pemetrexed and Cisplatin...
https://eprints.ncl.ac.uk/64423
Pemetrexed disodium, a novel antifolate with multiple targets - ePrints - Newcastle University
a novelpemetrexedantifolate
https://adisinsight.springer.com/drugsafety/803928979?error=cookies_not_supported&code=97f2339c-8097-4aee-95af-73c40b17c13a
Pemetrexed - AdisInsight
A 62-year-old man with metastatic adenocarcinoma of the lung receiving maintenance pemetrexed experienced kidney injury manifesting as renal impairment with
pemetrexedadisinsight
https://research.birmingham.ac.uk/en/projects/a-randomised-double-blind-phase-2-study-of-two-doses-of-pemetrexe/
A Randomised, Double-Blind, Phase 2 Study of Two Doses of Pemetrexed in the Treatment of Platinum...
https://www.prnewswire.com/news-releases/accord-healthcare-adds-pemetrexed-injection-to-generic-chemotherapy-drug-portfolio-301622368.html
Accord Healthcare Adds Pemetrexed Injection to Generic Chemotherapy Drug Portfolio
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Pemetrexed Injection (Solution) to its line of chemotherapy...
accord healthcarepemetrexed injectionaddsgenericchemotherapy
https://app-stadare-prod-uks-frontend.azurewebsites.net/spirig-healthcare-ch/produkte-de/pemetrexed-spirig-hc
Pemetrexed Spirig HC | Spirig Healthcare AG
pemetrexedspirighcag
https://adisinsight.springer.com/trials/700205889?error=cookies_not_supported&code=a8ae7b72-3a23-422d-b4bf-4f274123fd61
A phase I study of pemetrexed and gefitinib in chemotherapy naive elderly patients with non- small...
This trial will investigate the tolerability and efficacy of gefitinib and pemetrexed in chemotherapy-naive elderly patients with non-small cell lung cancer
https://adisinsight.springer.com/drugsafety/803348086?error=cookies_not_supported&code=cc0e44c9-6f67-4694-aae5-7c17b276fb71
Pemetrexed - AdisInsight
A 43-year-old woman developed immediate type hypersensitivity of anaphylaxis during treatment with pemetrexed for lung adenocarcinoma. Subsequently, she
pemetrexedadisinsight
https://pubmed.ncbi.nlm.nih.gov/23857409/
The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based...
The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma
the issue
https://profiles.wustl.edu/en/publications/concurrent-pemetrexed-and-radiation-therapy-in-the-treatment-of-p/
Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III...
https://ipkitten.blogspot.com/2017/09/pemetrexed-pops-up-in-milan.html
Pemetrexed pops up in Milan - The IPKat
The IPKat blog reports on copyright, patent, trade mark, info-tech and confidentiality issues from a mainly UK and European perspective.
pemetrexedpopsmilan
https://ipbiz.blogspot.com/2017/01/cafc-affirms-sd-ind-in-lilly-v-teva-in.html
IPBiz: CAFC affirms SD Ind in Lilly v. Teva in pemetrexed case Teva loses;
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/16729-0522/
16729-0522 Pemetrexed - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedndc
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=21a607a6-1ec3-e61b-7d89-c71e3bdc2e3b&type=display
These highlights do not include all the information needed to use PEMETREXED FOR INJECTION safely...
https://adisinsight.springer.com/drugsafety/803067250?error=cookies_not_supported&code=d90f40a3-89a9-4f63-86e5-791c4f4958d9
Pemetrexed - AdisInsight
A man developed haemolytic anaemia while receiving pemetrexed for non-small cell lung cancer.The 67-year-old man was diagnosed with adenocarcinoma of the right
pemetrexedadisinsight
https://pubmed.ncbi.nlm.nih.gov/20727460/?dopt=Abstract
Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced...
The new targeted agent bevacizumab in combination with cisplatin and gemcitabine, and a third generation chemotherapy, pemetrexed, combined with cisplatin, are...
treatment foreffectivenessbevacizumabpemetrexed
https://research.birmingham.ac.uk/en/publications/safety-resource-use-and-quality-of-life-in-paramount-a-phase-iii-/
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed...
https://pure.psu.edu/en/publications/efficacy-and-safety-of-pemetrexed-maintenance-therapy-versus-best/
Efficacy and safety of pemetrexed maintenance therapy versus best supportive care in patients from...
efficacy and safety
https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1674/
J9292 Pemetrexed dipotassium - CanMED: HCPCS
CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedhcpcs
https://adisinsight.springer.com/drugsafety/803377036?error=cookies_not_supported&code=e13e78fe-0a2b-4282-a2bd-c64453d3b27d
Genotyping not useful in predicting pemetrexed-related toxicity - AdisInsight
Genotyping for methylenetetrahydrofolate reductase (MTHFR) polymorphisms and 5'-UTR- thymidylate synthase (TYMS) genotypes does not appear to be useful in
genotypingusefulpredictingpemetrexedrelated
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00781-3519/
00781-3519 Pemetrexed - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
pemetrexedndc